(Q38158240)

29 August 2017

title

The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity (English)

1 reference

29 August 2017

0 references

0 references

1 reference

Hongxiang Xie

1

1 reference

29 August 2017

Liangju Sheng

series ordinal

2

1 reference

29 August 2017

Hong Zhou

series ordinal

3

1 reference

29 August 2017

Jinchuan Yan

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

8 October 2013

1 reference

British Journal of Haematology

29 August 2017

published in

1 reference

29 August 2017

volume

164

1 reference

29 August 2017

issue

2

1 reference

29 August 2017

page(s)

165-176

1 reference

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.

29 August 2017

cites work

1 reference

TLR2 is one of the endothelial receptors for beta 2-glycoprotein I.

21 January 2018

1 reference

A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies

21 January 2018

1 reference

β₂-Glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model.

21 January 2018

1 reference

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

21 January 2018

1 reference

Antiphospholipid antibodies, thrombin and LPS activate brain endothelial cells and Ras-dependent pathways through distinct mechanisms

21 January 2018

1 reference

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

21 January 2018

1 reference

Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies

21 January 2018

1 reference

The role of complement in the antiphospholipid syndrome-associated pathology

21 January 2018

1 reference

Leucine-rich repeats and pathogen recognition in Toll-like receptors.

21 January 2018

1 reference

Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion.

21 January 2018

1 reference

The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies

21 January 2018

1 reference

Role of tissue factor in thrombosis in antiphospholipid antibody syndrome

21 January 2018

1 reference

Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure

21 January 2018

1 reference

Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome

21 January 2018

1 reference

Oxidized beta2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response

21 January 2018

1 reference

Bidirectional effects on autoimmunity and reproduction

21 January 2018

1 reference

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe

21 January 2018

1 reference

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

21 January 2018

1 reference

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

21 January 2018

1 reference

Modulation of toll-like receptor function has therapeutic potential in autoimmune disease

21 January 2018

1 reference

Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis

21 January 2018

1 reference

Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression

21 January 2018

1 reference

Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members.

21 January 2018

1 reference

The obstetric antiphospholipid syndrome

21 January 2018

1 reference

Endogenous ligands of TLR2 and TLR4: agonists or assistants?

21 January 2018

1 reference

Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor

21 January 2018

1 reference

Obstetric antiphospholipid syndrome

21 January 2018

1 reference

Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

21 January 2018

1 reference

Current concepts on the pathogenesis of the antiphospholipid syndrome

21 January 2018

1 reference

Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule

21 January 2018

1 reference

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

A role for Toll-like receptor mediated signals in neutrophils in the pathogenesis of the anti-phospholipid syndrome

21 January 2018

1 reference

β(2) -Glycoprotein I: evolution, structure and function.

21 January 2018

1 reference

The role of LRP8 (ApoER2') in the pathophysiology of the antiphospholipid syndrome

21 January 2018

1 reference

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

21 January 2018

1 reference

Heparin prevents programmed cell death in human trophoblast

21 January 2018

1 reference

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

A role for calreticulin in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept

21 January 2018

1 reference

Intracellular trafficking of beta2-glycoprotein I complexes with lipid vesicles in macrophages: implications on the development of antiphospholipid syndrome

21 January 2018

1 reference

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

21 January 2018

1 reference

Effects of polyclonal IgG derived from patients with different clinical types of the antiphospholipid syndrome on monocyte signaling pathways.

21 January 2018

1 reference

Interaction of β2-glycoprotein I with lipopolysaccharide leads to Toll-like receptor 4 (TLR4)-dependent activation of macrophages

21 January 2018

1 reference

Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus

21 January 2018

1 reference

The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.

21 January 2018

1 reference

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

21 January 2018

1 reference

High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II

21 January 2018

1 reference

Obstetric and vascular APS: same autoantibodies but different diseases?

21 January 2018

1 reference

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies

21 January 2018

1 reference

Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway

21 January 2018

1 reference

Signaling in innate immunity and inflammation

21 January 2018

1 reference

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus

21 January 2018

1 reference

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

Deciphering the complexity of Toll-like receptor signaling

21 January 2018

1 reference

Tissue factor and thrombosis: The clot starts here.

21 January 2018

1 reference

Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity

21 January 2018

1 reference

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

21 January 2018

1 reference

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

21 January 2018

1 reference

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

21 January 2018

1 reference

Murine retroviruses activate B cells via interaction with toll-like receptor 4

21 January 2018

1 reference

The dual role of innate immunity in the antiphospholipid syndrome

21 January 2018

1 reference

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

21 January 2018

1 reference

Taxanes inhibit human TLR4 signaling by binding to MD-2.

21 January 2018

1 reference

Endothelium as a target for antiphospholipid antibodies.

21 January 2018

1 reference

Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo

21 January 2018

1 reference

Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome

21 January 2018

1 reference

Antiphospholipid antibodies, antiphospholipid syndrome and infections

21 January 2018

1 reference

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin

21 January 2018

1 reference

Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome

21 January 2018

1 reference

Infectious origin of the antiphospholipid syndrome

21 January 2018

1 reference

{beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome

21 January 2018

1 reference

Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome

21 January 2018

1 reference

Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits

21 January 2018

1 reference

The interplay between the antiphospholipid syndrome and systemic lupus erythematosus

21 January 2018

1 reference

Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome.

21 January 2018

1 reference

Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'.

21 January 2018

1 reference

Involvement of IRAKs and TRAFs in anti-β₂GPI/β₂GPI-induced tissue factor expression in THP-1 cells.

21 January 2018

1 reference

Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep

21 January 2018

1 reference

Annexin A2 mediates anti-beta 2 GPI/beta 2 GPI-induced tissue factor expression on monocytes

21 January 2018

1 reference

Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1 cells

21 January 2018

1 reference

Activation of MAPKs in the anti-β2GPI/β2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells

21 January 2018

1 reference

Paclitaxel binding to human and murine MD-2.

21 January 2018

1 reference

Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure

21 January 2018

1 reference

Annexin A2 mediates endothelial cell activation by antiphospholipid/anti- 2 glycoprotein I antibodies

21 January 2018

1 reference

Anti–β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12587

1 reference

29 August 2017

1 reference